Vbi Vaccines Inc CS (VBIV)
$4.25
0.04 (0.83%)
VBIV Stock Quote Delayed 30 Minutes
Previous Close
$4.25
Market Cap
272.01M
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
5.85M
Day's Range
4.13 - 4.44
52-Week Range
0.47 - 6.93
Dividend & Yield
N/A (N/A)
VBIV Stock Predictions, Articles, and Vbi Vaccines Inc CS News
While Risks Remain, VBI Vaccines Stock Is a Buy at Today’s Prices
Sci-B-Vac's success will make or break VBIV stock. But the shares' recent pullback may have created a great buying opportunity.
Is It Time to Go Long on VBIV Stock?
As a speculative pharmaceutical investment, VBIV stock is not for the faint of heart. However, the underlying business suggests some rationale for longer-term optimism.
VBI Vaccines News: VBIV Stock Skyrockets 17% on Clinical Trial Success
VBI Vaccines (VBIV) news for Monday about results from a recent clinical trial of a hepatitis B vaccine have VBI stock soaring.
5 Stocks to Buy Based on Insider Buying
These are five stocks to consider buying because of significant insider buying activity. Insiders only buy for one reason: to make money.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
A
